secwatch.observer — SEC 8-K summary
======================================

Issuer:     CapsoVision, Inc (CV)
CIK:        0001378325
Form:       8-K
Filed at:   2025-09-26T23:59:59+00:00
Accession:  0001378325-25-000022
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

CapsoVision Senior Director of Clinical Affairs to retire; Keri Jorgenson promoted
--------------------------------------------------------------------------------

- Rebecca Petersen to retire as Senior Director of Clinical Affairs effective Oct 15, 2025.
- Keri Jorgenson promoted to Director of Clinical Operations, assuming clinical development responsibilities.
- Petersen to provide consulting at $150/hour starting Oct 16; unvested stock options continue vesting.
- Company expects no disruption to clinical development operations during transition.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1378325/000137832525000022/0001378325-25-000022-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1378325/000137832525000022/cv-20250922.htm
  HTML page:      https://secwatch.observer/filing/0001378325-25-000022

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer